-
Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion
•
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant Alibaba Group, has announced strategic collaboration agreements with a consortium of pharmaceutical companies. The collaborations include US-based Viatris (NASDAQ: VTRS) and Chinese firms Qilu Pharmaceutical, Chongqing Taiji Industry (Group) Co., Ltd (SHA: 600129), Shandong Dyne…
-
Ant Group Eyes Acquisition of Leading Internet Healthcare Platform Haodf.com
•
Ant Group, the China-based fintech powerhouse, is reportedly pursuing the acquisition of Haodf.com, one of the country’s leading Internet healthcare platforms. This shift in negotiations comes after Alibaba Health Information Technology Ltd (HKG: 0241), Ant’s sister company, previously engaged in discussions with Haodf.com, according to local media sources. The two…
-
Alibaba Health Reports 12.7% Revenue Growth in H1 2023, Driven by Pharmaceutical and Digital Services
•
Alibaba Health Information Technology Ltd (HKG: 0241), based in China, has released its financial results for the first half of 2023, ending September 30, reporting revenues of RMB 12.956 billion. This represents a year-on-year increase of 12.7%, driven by robust growth in its pharmaceutical self-operated business as well as its…
